Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 41 out of 100. Getting a diagnosis

Topic: Risk, prevention and care in population studies

Early detection of abnormal neurodegeneration amidst normal cognitive aging is crucial. Subjective cognitive decline (SCD) may indicate Alzheimer's disease (AD) onset. Thus, we assess cognitive domains across the aging spectrum using simple neuropsychological tools. In this cross-sectional study, we examined 44 SCD individuals, 40 older controls (OC), and 20 young controls (YC) aged 40-60 years. Participants underwent demographic assessments, history evaluations, and screening using the Geriatric Depression and Anxiety Scales and the Clinical Dementia Rating (CDR) scale. Cognitive assessments included the PGI Memory Scale (PGIMS) and Stroop test, measuring memory and executive function. Both SCD and OC scored notably lower than YC in verbal retention of dissimilar words (Coefficient: -0.34, 95% CI: -0.64 to -0.04) and in the Stroop word test (SCD Co-efficient: -0.08, 95% CI: -0.16 to 0.01 and OC Co-efficient: -0.07, 95% CI: -0.14 to 0.01) and the Stroop Color test (SCD Coefficient: -0.19; 95% CI: -0.31 to -0.07 and OC Co-efficient: -0.10, 95% CI: -0.21 to 0.01). SCD individuals scored significantly lower in the Stroop color-word tests (SCWT), and delayed recall memory in PGIMS (Co-efficient: -0.11, 95%CI: -0.21 to -0.02) and -0.62; 95% CI: -1.19 to -0.04, respectively). Cognitive aging affects auditory short-term memory and processing speed while preserving mental balance. SCD is marked by deficits in delayed recall and executive function, suggesting early cognitive decline. Identifying these impairments with simple neuropsychological tools aids early detection, but further research with larger samples, longitudinal data, and biomarkers is needed to refine diagnosis and track neurodegeneration.

Key findings

Why it matters

In this cross-sectional study, individuals with subjective cognitive decline scored significantly lower on Stroop color-word tests and delayed recall memory compared with controls. It examines cognitive differences across aging and subjective cognitive decline but does not test any treatment, cure or prevention.

Study details

How this study scored 41/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 4 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 2 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 41 of 100.41 of 100 points earned59 not earned

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Archives of Gerontology and Geriatrics Plus)
Journal's citation record 0 / 4 Archives of Gerontology and Geriatrics Plus: journal h-index 12 (OpenAlex, 2026-10-29)
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Prasun Chatterjee: h-index 16 (OpenAlex, whole career)
Institution's track record 2 / 3 University of California, San Francisco: institution h-index 1,915 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 6 institution(s) in 3 countries
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 41 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Rao, A., Rao, A. R., Painkra, B., Kiruthika, S., Kumar, S., Thakral, M., et al. (2025). Cognitive assessment across normal aging and subjective cognitive decline using PGIMS and Stroop color-word test: A cross-sectional study. Archives of Gerontology and Geriatrics Plus. https://doi.org/10.1016/j.aggp.2025.100133

Vancouver

Rao A, Rao AR, Painkra B, Kiruthika S, Kumar S, Thakral M, et al. Cognitive assessment across normal aging and subjective cognitive decline using PGIMS and Stroop color-word test: A cross-sectional study. Archives of Gerontology and Geriatrics Plus. 2025. doi:10.1016/j.aggp.2025.100133.

BibTeX

@article{rao2025-3faadad1,
  author  = {Rao, Akshata and Rao, Abhijith Rajaram and Painkra, Bhawana and Kiruthika, Sakthi and Kumar, Sunil and Thakral, Meenal and Bajpai, Swati and Aithal, Shodhan and others},
  title   = {{Cognitive assessment across normal aging and subjective cognitive decline using PGIMS and Stroop color-word test: A cross-sectional study}},
  journal = {Archives of Gerontology and Geriatrics Plus},
  year    = {2025},
  doi     = {10.1016/j.aggp.2025.100133},
  url     = {https://doi.org/10.1016/j.aggp.2025.100133}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Getting a diagnosis

Also tagged “assessment”

840 studies in the library carry the topic tag “assessment”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →